Previous studies investigating the role of CXCL4 plasma levels in coronary artery disease have lead to conflicting results: While some studies found that elevated CXCL4 plasma levels were associated with CAD (but not with acute myocardial infarction) [16], others did not detect any differences [17]. This evidence concerns the gene PF4 and myocardial infarction.